How an investment in China's biggest baby formula maker fueled a monster earnings beat for Morgan Stanley
- Morgan Stanley reported an earnings beat on Thursday, sending shares nearly 8% higher.
- Investment revenues nearly doubled in the quarter thanks to a $50 million investment a Morgan Stanley PE fund in Asia made 6 years ago that grew to $2 billion, CFO Jon Pruzan said.
- The company is China Feihe, the largest producer of powdered milk in China, according to Bloomberg. China Feihe went public this year and has performed well since.
- Watch Morgan Stanley trade live on Markets Insider.
- Read more on Business Insider.
Morgan Stanley has China's biggest baby formula maker to thank for its strong earnings.
The US bank reported solid fourth-quarter and full year 2019 earnings Thursday, rounding out a strong week for US banks and sending shares nearly 8% higher.
While revenue from bond trading, fixed income trading, and wealth management rose, the bank's investment management division stood out from the rest. Even though it's the smallest business at the bank, it produced $1.4 billion in revenue, nearly double compared to a year earlier, Morgan Stanley said in a press release.
"The increase this quarter and year was primarily due to an underlying investment, IPO, subject to sales restrictions within an Asia private equity fund," chief financial officer Jon Pruzan said on a call with analysts Thursday.
While Pruzan didn't name the public company, Bloomberg identified it as China Feihe, the largest producer of powdered milk in China.
A Morgan Stanley private equity fund in Asia first invested $50 million in the company six years ago, according to Pruzan. That stake grew to a value of nearly $2 billion after China Feihe's public listing in 2019 and performance since, he said.
Morgan Stanley gained roughly 4% year to date through Wednesday's close.